Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Letter to the Editor

Clinical significance of the discrepancy between radiological findings and biochemical responses in atezolizumab plus bevacizumab for hepatocellular carcinoma

Hideki Iwamoto, Shigeo Shimose, Takashi Niizeki, Hironori Koga, Takuji Torimura

Clin Mol Hepatol. 2022;28(3):575-579. Published online April 21, 2022

DOI: https://doi.org/10.3350/cmh.2022.0047

View: 1055 Download: 152

Original Article

Gut-derived lipopolysaccharide promotes alcoholic hepatosteatosis and subsequent hepatocellular carcinoma by stimulating neutrophil extracellular traps through toll-like receptor 4

Yang Liu, Xin Zhang, Shuo Chen, Jiazhong Wang, Shuo Yu, Yiming Li, Meng Xu, Harouna Aboubacar, Junhui Li, Tao Shan, Jixin Wang, Gang Cao

Clin Mol Hepatol. 2022;28(3):522-539. Published online May 4, 2022

DOI: https://doi.org/10.3350/cmh.2022.0039

View: 1380 Download: 91 Citation: 1

Review

Intrahepatic cholangiocarcinoma: Tumour heterogeneity and its clinical relevance

Mina Komuta

Clin Mol Hepatol. 2022;28(3):396-407. Published online January 14, 2022

DOI: https://doi.org/10.3350/cmh.2021.0287

View: 1949 Download: 222 Citation: 1

Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?

Myung Ji Goh, Dong Hyun Sinn

Clin Mol Hepatol. 2022;28(3):380-395. Published online January 13, 2022

DOI: https://doi.org/10.3350/cmh.2021.0366

View: 1605 Download: 99

Imaging diagnosis of hepatocellular carcinoma: Future directions with special emphasis on hepatobiliary magnetic resonance imaging and contrast-enhanced ultrasound

Junghoan Park, Jeong Min Lee, Tae-Hyung Kim, Jeong Hee Yoon

Clin Mol Hepatol. 2022;28(3):362-379. Published online December 27, 2021

DOI: https://doi.org/10.3350/cmh.2021.0361

View: 1766 Download: 143

The best predictive model for hepatocellular carcinoma in patients with chronic hepatitis B infection

Jung Hwan Yu, Soon Gu Cho, Young-Joo Jin, Jin-Woo Lee

Clin Mol Hepatol. 2022;28(3):351-361. Published online November 26, 2021

DOI: https://doi.org/10.3350/cmh.2021.0281

View: 1941 Download: 154

Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma

Pil Soo Sung

Clin Mol Hepatol. 2022;28(3):333-350. Published online October 19, 2021

DOI: https://doi.org/10.3350/cmh.2021.0308

View: 12468 Download: 245 Citations: 3

Original Article

Surgery versus radiofrequency ablation in patients with Child- Pugh class-A/single small (≤3 cm) hepatocellular carcinoma

Jungnam Lee, Young-Joo Jin, Seung Kak Shin, Jung Hyun Kwon, Sang Gyune Kim, Young Ju Suh, Yujin Jeong, Jung Hwan Yu, Jin-Woo Lee, Oh Sang Kwon, Soon Woo Nahm, Young Seok Kim

Clin Mol Hepatol. 2022;28(2):207-218. Published online November 24, 2021

DOI: https://doi.org/10.3350/cmh.2021.0294

View: 2000 Download: 152 Citation: 1

Editorial

Surgical resection versus ablation for early hepatocellular carcinoma: The debate is still open

Bo Hyun Kim

Clin Mol Hepatol. 2022;28(2):174-176. Published online January 26, 2022

DOI: https://doi.org/10.3350/cmh.2021.0400

View: 1280 Download: 65

Review

The management of post-transplantation recurrence of hepatocellular carcinoma

Luckshi Rajendran, Tommy Ivanics, Marco PAW Claasen, Hala Muaddi, Gonzalo Sapisochin

Clin Mol Hepatol. 2022;28(1):1-16. Published online October 5, 2021

DOI: https://doi.org/10.3350/cmh.2021.0217

View: 3275 Download: 192

Letter to the Editor

Impact of branched-chain amino acids and frailty on the management of lenvatinib-related fatigue in patients with hepatocellular carcinoma

Shigeo Shimose, Shunji Koya, Takumi Kawaguchi, Keisuke Hirota, Sachiyo Yoshio, Takashi Niizeki, Hiroo Matsuse, Takuji Torimura

Clin Mol Hepatol. 2021;27(4):616-619. Published online September 13, 2021

DOI: https://doi.org/10.3350/cmh.2021.0258

View: 2139 Download: 168

Original Article

Impact of everolimus on survival after liver transplantation for hepatocellular carcinoma

Incheon Kang, Jae Geun Lee, Sung Hoon Choi, Hyun Jeong Kim, Dai Hoon Han, Gi Hong Choi, Myoung Soo Kim, Jin Sub Choi, Soon Il Kim, Dong Jin Joo

Clin Mol Hepatol. 2021;27(4):589-602. Published online July 23, 2021

DOI: https://doi.org/10.3350/cmh.2021.0038

View: 2537 Download: 179 Citations: 5

New next-generation microwave thermosphere ablation for small hepatocellular carcinoma

Hideyuki Tamai, Jumpei Okamura

Clin Mol Hepatol. 2021;27(4):564-574. Published online August 2, 2021

DOI: https://doi.org/10.3350/cmh.2021.0136

View: 2455 Download: 186 Citations: 2

Editorial

Can hepatocellular carcinoma recurrence be prevented after liver transplantation?

Jong Man Kim

Clin Mol Hepatol. 2021;27(4):562-563. Published online September 23, 2021

DOI: https://doi.org/10.3350/cmh.2021.0276

View: 1711 Download: 92 Citation: 1

Microwave thermosphere versus radiofrequency ablation for hepatocellular carcinoma: Are we approaching the time to end the debate?

Man-Deuk Kim

Clin Mol Hepatol. 2021;27(4):560-561. Published online September 8, 2021

DOI: https://doi.org/10.3350/cmh.2021.0279

View: 1745 Download: 90

Review

Three heads are better than two: Hepatitis B core-related antigen as a new predictor of hepatitis B virus-related hepatocellular carcinoma

Jer-Wei Wu, Jia-Horng Kao, Tai-Chung Tseng

Clin Mol Hepatol. 2021;27(4):524-534. Published online February 23, 2021

DOI: https://doi.org/10.3350/cmh.2021.0012

View: 9864 Download: 272 Citations: 7

Special Topic

Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline

Ju-Yeon Cho, Young-Sun Lee, Soon Sun Kim, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim

Clin Mol Hepatol. 2021;27(4):515-523. Published online September 17, 2021

DOI: https://doi.org/10.3350/cmh.2021.0293

View: 3279 Download: 57 Citation: 1

Snapshot

Hepatocellular carcinoma statistics in South Korea

Young Eun Chon, Soung Won Jeong, Dae Won Jun

Clin Mol Hepatol. 2021;27(3):512-514. Published online June 21, 2021

DOI: https://doi.org/10.3350/cmh.2021.0171

View: 2661 Download: 120 Citations: 7

Original Article

Serum fibrosis index-based risk score predicts hepatocellular carcinoma in untreated patients with chronic hepatitis B

Lilian Yan Liang, Hye Won Lee, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip, Yee-Kit Tse, Vicki Wing-Ki Hui, Grace Chung-Yan Lui, Henry Lik-Yuen Chan, Grace Lai-Hung Wong

Clin Mol Hepatol. 2021;27(3):499-509. Published online February 26, 2021

DOI: https://doi.org/10.3350/cmh.2020.0333

View: 2190 Download: 126 Citations: 2

Editorial

Risk of hepatocellular carcinoma in untreated patients with chronic hepatitis B: Independent of HBeAg status?

Ho Soo Chun, Minjong Lee

Clin Mol Hepatol. 2021;27(3):448-450. Published online June 23, 2021

DOI: https://doi.org/10.3350/cmh.2021.0130

View: 1843 Download: 95

Review

Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma

Sung Won Lee, Jonggi Choi, Seung Up Kim, Young-Suk Lim

Clin Mol Hepatol. 2021;27(3):402-412. Published online June 23, 2021

DOI: https://doi.org/10.3350/cmh.2021.0179

View: 3006 Download: 206 Citations: 12

Original Article

Significant down-regulation of growth hormone receptor expression revealed as a new unfavorable prognostic factor in hepatitis C virus-related hepatocellular carcinoma

Ching-Chih Lin, Ta-Wei Liu, Ming-Lun Yeh, Yi-Shan Tsai, Pei-Chien Tsai, Chung-Feng Huang, Jee-Fu Huang, Wan-Long Chuang, Chia-Yen Dai, Ming-Lung Yu

Clin Mol Hepatol. 2021;27(2):313-328. Published online December 14, 2020

DOI: https://doi.org/10.3350/cmh.2020.0247

View: 7658 Download: 128 Citations: 3

Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B

Mi Young Jeon, Beom Kyung Kim, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim

Clin Mol Hepatol. 2021;27(2):295-304. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0216

View: 2882 Download: 167 Citations: 5

Review

Optimizing the management of intermediate-stage hepatocellular carcinoma: Current trends and prospects

Takuji Torimura, Hideki Iwamoto

Clin Mol Hepatol. 2021;27(2):236-245. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0204

View: 4448 Download: 276 Citations: 11

Original Article

Obesity and the risk of primary liver cancer: A systematic review and meta-analysis

Won Sohn, Hyun Woong Lee, Sangheun Lee, Jin Hong Lim, Min Woo Lee, Chan Hyuk Park, Seung Kew Yoon

Clin Mol Hepatol. 2021;27(1):157-174. Published online November 26, 2020

DOI: https://doi.org/10.3350/cmh.2020.0176

View: 4212 Download: 274 Citations: 18

Radiation-induced abscopal effect and its enhancement by programmed cell death 1 blockade in the hepatocellular carcinoma: A murine model study

Gyu Sang Yoo, Won-Gyun Ahn, Shin-Yeong Kim, Wonseok Kang, Changhoon Choi, Hee Chul Park

Clin Mol Hepatol. 2021;27(1):144-156. Published online December 7, 2020

DOI: https://doi.org/10.3350/cmh.2020.0095

View: 4034 Download: 212 Citations: 8

Editorial

Old hepatitis B virus never dies: It just hides itself within the host genome

Jeong-Hoon Lee

Clin Mol Hepatol. 2021;27(1):107-109. Published online December 23, 2020

DOI: https://doi.org/10.3350/cmh.2020.0324

View: 2066 Download: 92 Citations: 2

Exploring the mythical abscopal effect: Radiation and programmed cell death protein 1 (PD-1) blockade for hepatocellular carcinoma

Jun Won Kim, Ik Jae Lee

Clin Mol Hepatol. 2021;27(1):103-106. Published online December 14, 2020

DOI: https://doi.org/10.3350/cmh.2020.0297

View: 1905 Download: 83

Metabolic disease as a risk of hepatocellular carcinoma

Naoshi Nishida

Clin Mol Hepatol. 2021;27(1):87-90. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0302

View: 2534 Download: 88 Citations: 7

Special topic: Alcoholic liver diseases The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)

Hepatic Hippo signaling inhibits development of hepatocellular carcinoma

Yuchen Liu, Xiaohui Wang, Yingzi Yang

Clin Mol Hepatol. 2020;26(4):742-750. Published online September 28, 2020

DOI: https://doi.org/10.3350/cmh.2020.0178

View: 4074 Download: 157 Citations: 22

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next

Viewed By 9420	Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma
Viewed By 4697	A cost-effectiveness study of universal screening for hepatitis C virus infection in South Korea: A societal perspective
Viewed By 3172	KASL clinical practice guidelines for management of chronic hepatitis B
Viewed By 2309	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Viewed By 2108	The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future

Cited By 45	Trends in the prevalence of chronic liver disease in the Korean adult population, 1998–2017
Cited By 38	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Cited By 35	Application of transient elastography in nonalcoholic fatty liver disease
Cited By 33	KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications
Cited By 33	Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop

Search